SECOND OPINION: BIG PHARMA GAMES THE PATENT SYSTEM TO HIKE PRICES AND BOOST PROFITS — NOT ‘DRIVE INNOVATION’ OR ‘ENHANCE PATIENT ACCESS’
Drug Companies’ Anti-Competitive Gamesmanship Comes At Tremendous Cost To… Read More
Drug Companies’ Anti-Competitive Gamesmanship Comes At Tremendous Cost To… Read More
Brand Name Big Pharma Giant Surpasses Expectations After Hiking Prices A new… Read More
Brand Name Drug Companies Beat Wall Street Expectations After Repeatedly… Read More
Big Pharma’s Pandemic Price Hikes and Patent Abuse Underscore Urgency for… Read More
Price Hikes Fuel Q3 Earnings Beat For Brand Name Giant As millions of… Read More
Surrogates for the 2020 Candidates Should Demonstrate Commitment To Lowering… Read More
Big Pharma Claims Misguided Proposal Would Benefit Patients, Facts Show It… Read More
Lawmakers Blast Big Pharma Executives During Two-Day Hearing on… Read More
Brand Name Drug Company Shirks Requirement to Provide Affordable Medications… Read More
House Committee on Oversight and Reform to Question Big Pharma Executives… Read More
Brand Name Drug Companies Must be Held Accountable for Pandemic Price Hikes… Read More
Report Finds Market-Based Solutions to Boost Biosimilar Competition and Hold… Read More